An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Clinical trial NCT06334120 · RECRUITING

Trial details

NCT number: NCT06334120
Sponsor: Bayer
Status: RECRUITING
Study type: OBSERVATIONAL

Non-metastatic Castration-resistant Prostate Cancer Metastatic Hormone-sensitive Prostate Cancer

Start date: 2024-09-25
Primary completion: 2028-03-31
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.